Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-26-006047

General Counsel sold 12,253 shares at $3.31 ($40,582)

From the SEC's structured data for this filing

Trades in this filing

Wilson Martin · General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-02-13 Sale : show line 1 in the form −12,253 $3.31 $40,582 683,376 D
Open-market sales · 12,253 sh · avg $3.31 · $40,582
Loading xslF345X05/form4.xml…